Basics Enliven Therapeutics, Inc. IPO Date: February 24, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.26B Activated in VL: True Average Daily Range Avg Daily Range: $0.60 | 3.13% Avg Daily Range (30 D): $0.53 | 2.63% Avg Daily Range (90 D): $0.55 | 2.67% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .39M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 615 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $1.8M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.43M Avg Closing Trade (30 D): $1.63M Avg Closing Trade (90 D): $1.33M Avg Closing Volume: 68.18K     News Aug 13, 2025 @ 10:15 PM Enliven Posts Loss Beat and Cash Surge Source: Jesterai Oct 14, 2024 @ 7:05 PM Enliven Therapeutics, Inc. Is a Great Choice for '... Source: Zacks Sep 28, 2024 @ 1:35 PM Enliven Therapeutics Announces Positive Data Updat... Source: N/A Jul 16, 2024 @ 10:44 PM Enliven Therapeutics COO sells over $1.25m in comp... Source: Investing.Com May 29, 2024 @ 8:05 PM Enliven Therapeutics to Present at Two Upcoming In... Source: Enliven Therapeutics, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.57 $-.46 $-1.89 Diluted EPS $-.57 $-.46 $-1.89 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -28.54M $ -23.18M $ -89.02M Operating Income / Loss $ -31.69M $ -26.9M $ -104.55M Cost of Revenue $ $ $ Net Cash Flow $ -22.47M $ 23.5M $ 23.98M PE Ratio